- Home
- HALO vs CFLT Comparison
HALO vs CFLT Comparison
Compare HALO & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- CFLT
- Stock Information
- Founded
- HALO 1998
- CFLT 2014
- Country
- HALO United States
- CFLT United States
- Employees
- HALO N/A
- CFLT N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- CFLT EDP Services
- Sector
- HALO Health Care
- CFLT Technology
- Exchange
- HALO Nasdaq
- CFLT Nasdaq
- Market Cap
- HALO 7.4B
- CFLT 8.1B
- IPO Year
- HALO N/A
- CFLT 2021
- Fundamental
- Price
- HALO $54.54
- CFLT $21.96
- Analyst Decision
- HALO Buy
- CFLT Buy
- Analyst Count
- HALO 9
- CFLT 30
- Target Price
- HALO $63.56
- CFLT $31.00
- AVG Volume (30 Days)
- HALO 3.3M
- CFLT 7.4M
- Earning Date
- HALO 05-06-2025
- CFLT 04-30-2025
- Dividend Yield
- HALO N/A
- CFLT N/A
- EPS Growth
- HALO 55.40
- CFLT N/A
- EPS
- HALO 3.76
- CFLT N/A
- Revenue
- HALO $1,084,306,000.00
- CFLT $1,017,525,000.00
- Revenue This Year
- HALO $25.77
- CFLT $21.52
- Revenue Next Year
- HALO $18.01
- CFLT $18.45
- P/E Ratio
- HALO $14.51
- CFLT N/A
- Revenue Growth
- HALO 25.64
- CFLT 24.11
- 52 Week Low
- HALO $42.01
- CFLT $17.79
- 52 Week High
- HALO $70.51
- CFLT $37.90
- Technical
- Relative Strength Index (RSI)
- HALO 44.48
- CFLT 47.59
- Support Level
- HALO $52.43
- CFLT $20.95
- Resistance Level
- HALO $54.26
- CFLT $22.05
- Average True Range (ATR)
- HALO 3.42
- CFLT 0.79
- MACD
- HALO -0.49
- CFLT 0.10
- Stochastic Oscillator
- HALO 30.60
- CFLT 55.93
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About CFLT Confluent Inc.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.